Selection criteria for the clinical use of the newer antiepileptic drugs.

Deckers CLP, Knoester PD, de Haan GJ, Keyser A, Renier WO, Hekster YA. Selection criteria for the clinical use of the newer antiepileptic drugs. CNS Drugs. 2003;17(6):405-21. PubMed PMID: 12697000.

Safety and efficacy of standard and new antiepileptic drugs.

Devinsky O, Cramer J. Safety and efficacy of standard and new antiepileptic drugs. Neurology. 2000;55(11 Suppl 3):S5-10. PubMed PMID: 11147569.

Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.

Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. Jama Pediatr. 2014;168(8):729-36. DOI: 10.1001/jamapediatrics.2014.118. PubMed PMID: 24934501; PubMed Central PMCID: PMC4122685.

A systematic review of antiepileptic drug initiation and withdrawal.

Shih JJ, Ochoa JG. A systematic review of antiepileptic drug initiation and withdrawal. Neurologist. 2009;15(3):122-31. DOI: 10.1097/NRL.0b013e3181901ad3. PubMed PMID: 19430266.

The ideal characteristics of antiepileptic therapy: an overview of old and new AEDs.

Steinhoff BJ, Hirsch E, Mutani R, Nakken KO. The ideal characteristics of antiepileptic therapy: an overview of old and new AEDs. Acta Neurol Scand. 2003;107(2):87-95. PubMed PMID: 12580856.

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Asses

Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ, et al. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Asses. Neurology. 2009;73(2):142-9. DOI: 10.1212/WNL.0b013e3181a6b325. PubMed PMID: 19398680; PubMed Central PMCID: PMC3475193.

Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects.

Anderson GD, Saneto RP. Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects. CNS Drugs. 2015;29(8):669-81. DOI: 10.1007/s40263-015-0268-5. PubMed PMID: 26369919.

Lamotrigine-associated rash: to rechallenge or not to rechallenge?

Lorberg B, Youssef NA, Bhagwagar Z. Lamotrigine-associated rash: to rechallenge or not to rechallenge?. Int J Neuropsychopharmacol. 2009;12(2):257-65. DOI: 10.1017/S1461145708009504. PubMed PMID: 18845017.

Hormone replacement therapy with estrogens may reduce lamotrigine serum concentrations: A matched case-control study.

Reimers A. Hormone replacement therapy with estrogens may reduce lamotrigine serum concentrations: A matched case-control study. Epilepsia. 2017;58(1):e6-e9. DOI: 10.1111/epi.13597. PubMed PMID: 27805259.

Women are unaware of pregnancy risks linked with sodium valproate.

Kmietowicz Z. Women are unaware of pregnancy risks linked with sodium valproate. BMJ. 2016;355:i5829. DOI: 10.1136/bmj.i5829. PubMed PMID: 27799146.